
Jane J. Zara
Examiner (ID: 18595)
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1674, 1637, 1635 |
| Total Applications | 1842 |
| Issued Applications | 1032 |
| Pending Applications | 285 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11219144
[patent_doc_number] => 09447471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Microrna profiling for diagnosis of dysplastic nevi and melanoma'
[patent_app_type] => utility
[patent_app_number] => 13/728053
[patent_app_country] => US
[patent_app_date] => 2012-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 28985
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13728053
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/728053 | Microrna profiling for diagnosis of dysplastic nevi and melanoma | Dec 26, 2012 | Issued |
Array
(
[id] => 8841967
[patent_doc_number] => 20130137596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors'
[patent_app_type] => utility
[patent_app_number] => 13/727794
[patent_app_country] => US
[patent_app_date] => 2012-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33653
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13727794
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/727794 | MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors | Dec 26, 2012 | Abandoned |
Array
(
[id] => 9307035
[patent_doc_number] => 20140045709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors'
[patent_app_type] => utility
[patent_app_number] => 13/727785
[patent_app_country] => US
[patent_app_date] => 2012-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33627
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13727785
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/727785 | MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors | Dec 26, 2012 | Abandoned |
Array
(
[id] => 8891661
[patent_doc_number] => 20130164845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'Compositions and Methods for the Delivery of Biologically Active RNAs'
[patent_app_type] => utility
[patent_app_number] => 13/726337
[patent_app_country] => US
[patent_app_date] => 2012-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 70565
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13726337
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/726337 | Compositions and Methods for the Delivery of Biologically Active RNAs | Dec 23, 2012 | Abandoned |
Array
(
[id] => 8904901
[patent_doc_number] => 20130172404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'Delivery of Oligonucleotide Functionalized Nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/721366
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 25166
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13721366
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/721366 | Delivery of oligonucleotide functionalized nanoparticles | Dec 19, 2012 | Issued |
Array
(
[id] => 10414700
[patent_doc_number] => 20150299710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'Inhibitory Oligonucleotide and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/442799
[patent_app_country] => US
[patent_app_date] => 2012-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10203
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442799
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442799 | Inhibitory oligonucleotide and use thereof | Nov 28, 2012 | Issued |
Array
(
[id] => 11263522
[patent_doc_number] => 09487809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-08
[patent_title] => 'Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase'
[patent_app_type] => utility
[patent_app_number] => 13/688075
[patent_app_country] => US
[patent_app_date] => 2012-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20545
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13688075
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/688075 | Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase | Nov 27, 2012 | Issued |
Array
(
[id] => 9626282
[patent_doc_number] => 08795959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-05
[patent_title] => 'Isolated glucokinase genomic polynucleotide fragments from chromosome 7'
[patent_app_type] => utility
[patent_app_number] => 13/680178
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12918
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680178
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680178 | Isolated glucokinase genomic polynucleotide fragments from chromosome 7 | Nov 18, 2012 | Issued |
Array
(
[id] => 8829207
[patent_doc_number] => 20130130252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'IDENTIFICATION OF POLD2 SEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 13/680223
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12916
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680223
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680223 | Identification of POLD2 sequences | Nov 18, 2012 | Issued |
Array
(
[id] => 10355232
[patent_doc_number] => 20150240238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'THERAPEUTIC RNA SWITCHES COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/359019
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 23373
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14359019
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/359019 | THERAPEUTIC RNA SWITCHES COMPOSITIONS AND METHODS OF USE | Nov 18, 2012 | Abandoned |
Array
(
[id] => 11357576
[patent_doc_number] => 09534220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Antisense antibacterial method and compound'
[patent_app_type] => utility
[patent_app_number] => 13/680790
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 29
[patent_no_of_words] => 17751
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680790
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680790 | Antisense antibacterial method and compound | Nov 18, 2012 | Issued |
Array
(
[id] => 11357576
[patent_doc_number] => 09534220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Antisense antibacterial method and compound'
[patent_app_type] => utility
[patent_app_number] => 13/680790
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 29
[patent_no_of_words] => 17751
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680790
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680790 | Antisense antibacterial method and compound | Nov 18, 2012 | Issued |
Array
(
[id] => 11357576
[patent_doc_number] => 09534220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Antisense antibacterial method and compound'
[patent_app_type] => utility
[patent_app_number] => 13/680790
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 29
[patent_no_of_words] => 17751
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680790
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680790 | Antisense antibacterial method and compound | Nov 18, 2012 | Issued |
Array
(
[id] => 8829206
[patent_doc_number] => 20130130251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'IDENTIFICATION OF SNARE YKT6 SEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 13/680203
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12915
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680203
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680203 | IDENTIFICATION OF SNARE YKT6 SEQUENCES | Nov 18, 2012 | Abandoned |
Array
(
[id] => 11357576
[patent_doc_number] => 09534220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Antisense antibacterial method and compound'
[patent_app_type] => utility
[patent_app_number] => 13/680790
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 29
[patent_no_of_words] => 17751
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680790
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680790 | Antisense antibacterial method and compound | Nov 18, 2012 | Issued |
Array
(
[id] => 8815110
[patent_doc_number] => 20130116154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'METHOD AND SUBSTANCES FOR ISOLATION AND DETECTION OF SMALL POLYNUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/678368
[patent_app_country] => US
[patent_app_date] => 2012-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21440
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13678368
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/678368 | METHOD AND SUBSTANCES FOR ISOLATION AND DETECTION OF SMALL POLYNUCLEOTIDES | Nov 14, 2012 | Abandoned |
Array
(
[id] => 9957994
[patent_doc_number] => 09006199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'Methods and compositions for treating prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 13/676581
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 14553
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676581
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/676581 | Methods and compositions for treating prostate cancer | Nov 13, 2012 | Issued |
Array
(
[id] => 10857231
[patent_doc_number] => 08883425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts'
[patent_app_type] => utility
[patent_app_number] => 13/664027
[patent_app_country] => US
[patent_app_date] => 2012-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17279
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13664027
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/664027 | Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts | Oct 29, 2012 | Issued |
Array
(
[id] => 10498546
[patent_doc_number] => 09226936
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells'
[patent_app_type] => utility
[patent_app_number] => 14/350588
[patent_app_country] => US
[patent_app_date] => 2012-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 15715
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350588
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350588 | Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells | Oct 23, 2012 | Issued |
Array
(
[id] => 10347847
[patent_doc_number] => 20150232852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'Glucagon Binding Nucleic Acids'
[patent_app_type] => utility
[patent_app_number] => 14/351574
[patent_app_country] => US
[patent_app_date] => 2012-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 51623
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351574
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/351574 | Glucagon Binding Nucleic Acids | Oct 21, 2012 | Abandoned |